K Hospital pioneers vNOTES technique for gynecologic cancer, offering scar-free, minimally invasive treatment.

Magnetic resonance imaging (MRI) has been shown to have potential for characterizing adnexal masses [3,4]. These studies have shown that MRI is superior in identifying endometriomas, dermoids and ...

But when it's a fibroid tumor, experts say there is little to fear. "There is virtually no threat of malignancy -- and there are a number of excellent treatment options, as well as the option to ...

Please provide your email address to receive an email when new articles are posted on . Four adnexal mass classification algorithms successfully distinguished lesions when used by a novice operator.

Interventional radiology (IR) is transforming uterine fibroid and ovarian disorder treatment, offering innovative, less invasive alternatives to surgery. Uterine Fibroid Embolization (UFE ...

Uterine fibroids are tumors made of muscle that can grow on your uterus. They rarely turn into cancer. Many women have uterine fibroids. You might not even know you have them, since they don’t ...

To my surprise, it wasn’t. My doctor discovered I had a growth known as a uterine fibroid pushing down on my uterus, repositioning it (and my cervix). She stressed that these growths are so common in ...

Heavy periods are one of the hallmark signs of uterine fibroids, but there are other causes, too. Knowing the reason for your heavy menstrual bleeding is your key to managing it. Do you feel that ...

ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...

In recent years, there has been an increasing focus on the contributory role of uterine fibroids to infertility. The prevalence of these tumors increases with age, which becomes significant as ...

Swiss biopharma company ObsEva has filed its oral GnRH antagonist linzagolix for the treatment of uterine fibroids in the US, hoping to expand the number of women eligible for this type of therapy.

A daily oral therapy for uterine fibroids has been recommended for NHS by NICE, providing a new option for around 30,000 women in England and Wales. Theramex's GnRH antagonist Yselty (linzagolix ...